WSTAM
DPLO

Wilbanks Smith & Thomas Asset Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-343
Closed -$7K – 1509
2018
Q3 		$7K Buy
+343
New +$7.3K ﹤0.01% 1154

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's DPLO Position: Q4 2018 in Review

Wilbanks Smith & Thomas Asset Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2018, closing a stake of 343 shares — an estimated $7K sold.

Wilbanks Smith & Thomas Asset Management first reported a position in DPLO in Q3 2018 and held it in 1 quarter. The position peaked at $7K in Q3 2018. 157 funds tracked by Wall St. Rank hold DPLO as of Q4 2018.

  • Wilbanks Smith & Thomas Asset Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2018 after selling out during the quarter.
  • Wilbanks Smith & Thomas Asset Management sold 343 DIPLOMAT PHARMACY, INC. shares in Q4 2018, an estimated $7K.
  • Wilbanks Smith & Thomas Asset Management first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2018 and held it in 1 quarter.
  • Wilbanks Smith & Thomas Asset Management's DIPLOMAT PHARMACY, INC. position peaked at $7K in Q3 2018.
  • 157 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2018.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q4 2018, filed 8 Feb 2019.